Janine Jamieson
Janine Jamieson is European Editor - with special interest in Drug/Device Combination Products, International Pharmaceutical Quality. She shares the global regulatory dialogue around CMC/GMP challenges for biopharma, advanced therapies and combination products.
Meeting ReportMD5: Innovation in Drug-Device Combinations
The session was opened by Bjorg Hunter posing a question about how innovative companies can manage often complex and different global regulations when they are developing connected, environmentally friendly products for the benefit of the patients…
Meeting ReportIVD3: EU Implementation: Current State
The session was opened by Bjorg Hunter posing a question about how innovative companies can manage often complex and different global regulations when they are developing connected, environmentally friendly products for the benefit of the patients…